Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
about
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseFreeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease.Advances in understanding the pathogenesis of graft-versus-host disease.Regulatory T Cell Immunotherapy in Immune-Mediated DiseasesPreclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Pathophysiology of GvHD and Other HSCT-Related Major Complications.Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell TransplantationStrategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation.Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression.DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation.Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.Lymphocytes in Placental Tissues: Immune Regulation and Translational Possibilities for Immunotherapy.Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells.Human CD4- invariant NKT lymphocytes regulate graft versus host diseaseCulture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
P2860
Q28076264-49ACAE1B-479C-4F5D-AD9D-444EDA234C26Q35875324-98E58461-E5C9-4425-81D0-BA6B110E4F8FQ35971439-C17CB349-63A3-46B8-BD77-27FEF9A8A680Q36462109-E647F4A9-9CD5-4F65-AF92-BA5EC2CB8EE9Q37035815-5A22B479-1C22-417C-AD2F-F39D92DF4F09Q37443674-7B5B079B-D61C-4FFE-90AF-C019F1A4D8BDQ37710572-40487632-D433-4969-82DB-7D99F72025BCQ38616695-7C9FDC3D-EF30-4650-AE08-C78354E65BBCQ38640239-C0CB3575-CE44-4EA1-A979-A5B039CE088DQ38734173-6356F39E-38BA-433F-9CFE-C7C5518BB907Q38808955-E8046015-82EA-44FD-AEF4-58D047F397EAQ39114090-F63058A1-4BA5-466D-81F9-1667E13801F8Q42175189-AD66629B-C899-4021-A995-976455DFD5C1Q48214652-0130AA1C-91EF-4243-A16F-7E3B9F80A628Q52776444-6A429DD2-5192-4323-9700-533062859C6DQ58129678-2E7B4D4C-EFA8-4399-B705-49B42361CD63Q58799058-DFBA0A1D-3D62-4812-B04E-8E31C750C36B
P2860
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
@ast
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
@en
type
label
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
@ast
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
@en
prefLabel
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
@ast
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
@en
P2093
P2860
P1433
P1476
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
@en
P2093
Antonio Pierini
Corina Buechele
Dominik Schneidawind
Everett H Meyer
Jeanette Baker
Richard H Luong
Robert S Negrin
P2860
P304
P356
10.1182/BLOOD-2014-11-612762
P407
P577
2015-03-20T00:00:00Z